October 24-25, 2025
- Event: 3rd Annual Lung Cancer Interventions Summit
- Location: Chicago, IL
SCHEQ CEO, Eugene Manley, Jr., Ph.D., will convene industry experts, partners, and researchers to discuss the latest in providing equitable access and interventions for patients dealing with lung cancer.
Learning Objectives
Continuing our efforts to present solutions that reduce inequities in lung cancer, this conference will enable participants to:
- Identify key barriers to lung cancer screening, diagnosis, and treatment, and evaluate multi-level solutions including healthcare policy, hospital system interventions, and tobacco control efforts.
- Examine the role of patient and caregiver experiences in shaping lung cancer care, with an emphasis on patient advocacy, navigation services, and psychosocial support.
- Analyze recent advancements in lung cancer screening, early detection, biomarker development, and therapeutic strategies, including innovations in small cell lung cancer and clinical trial access.
- Evaluate the impact of environmental and social determinants of health, including tobacco use and community-specific factors, on lung cancer incidence and outcomes.
- Explore the application of artificial intelligence and machine learning in improving lung cancer diagnosis, treatment planning, and patient outcomes.
- Discuss the importance of translational research and mentorship programs in addressing knowledge gaps and increasing workforce diversity within the lung cancer care continuum.
- Design strategies for effective community engagement, patient education, and interdisciplinary collaboration to enhance lung cancer awareness, prevention, and care delivery.
If you are interested in exhibiting or sponsoring, contact us at sponsorships@scheq.org.
More information can be found and will be updated at: https://www.scheq.org/3rd-lung-cancer-interventions-summit
